PULMATRIX, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.91 USD | 0.00% |
|
+7.30% | +2.69% |
| May. 17 | Pulmatrix Files Up to $95 Million Mixed Shelf | MT |
| May. 15 | Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled Dhe for Acute Migraine | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PULMATRIX, INC. | Bio Therapeutic Drugs | 0.00% | +7.30% | +2.69% | -32.98% | -90.82% | 6.98M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- PULM Stock
- Charts Pulmatrix, Inc.
- Comparison Chart
